MANILA, Philippines – Department of Health (DOH) Secretary Francisco Duque III has created a task force that will review the implementation of the now-suspended dengue vaccination program and determine how to prevent a similar incident from happening again.
Duque said on Friday, December 8, that the task force is composed of top officials from the following:
“This task force will conduct a thorough review of the dengue vaccination initiative which started in March 2016 and the new evidence on safety provided by Sanofi,” said Duque in a statement. (READ: TIMELINE: Dengue immunization program for public school students)
“This shall guide the Department of Health in responding to the safety concerns relevant to the use of this vaccine and how to proceed with the dengue program to ensure safeguards and prevent similar incidents in the future,” he added.
Last week, French pharmaceutical giant Sanofi Pasteur announced that its Dengvaxia dengue vaccine may lead to “more severe” cases of dengue on a vaccinated person who had not been infected by the virus before.
Another 15,000 police officers, their relatives, and walk-in civilians also received the vaccine from an immunization program in Quezon City.
Now, Duque said he will demand that Sanofi refund the P3.5 billion the Philippine government paid for the Dengvaxia vaccine. (READ: Duque to go after Sanofi over dengue vaccine)
“We will demand the refund of the P3.5 billion paid for the Dengvaxia vaccine, and that Sanofi set up an indemnification fund to cover the hospitalization and medical treatment for all children who might have severe dengue,” he said.
The DOH will also be hiring 30 additional surveillance officers to be deployed in the regions where the vaccination program was conducted. DOH plans to closely monitor the vaccinated children for 5 years.
The DOH is currently updating its master list of students who received the vaccine.
Duque said PhilHealth is also ready to cover up to P16,000 worth of medical expenses of any child who will be hospitalized for severe dengue.
“We will continue to be vigilant in monitoring our children for any adverse event following immunization, and will strengthen the readiness of our public hospitals in attending to any severe dengue cases that may occur,” said Duque. – Rappler.com